Psychological treatment may reduce the need for healthcare in patients with Crohn's disease

被引:62
|
作者
Deter, Hans-Christian
Keller, Wolfram
von Wietersheim, Joern
Jantschek, Guenther
Duchmann, Rainer
Zeitz, Martin
机构
[1] Dept Psychosomat Med & Psychotherapy, D-12200 Berlin, Germany
[2] Med Univ Lubeck, Dept Psychosomat Med & Psychotherapy, Lubeck, Germany
[3] Med Clin Gastroenterol 1, Berlin, Germany
关键词
Crohn's disease; health care utilization; outcome study; psychological intervention;
D O I
10.1002/ibd.20068
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Few published studies examine the influence of psychological treatment on health care utilization in Crohn's disease. Methods: The present substudy of a prospective, randomized, multicenter trial conducted in 69 of 488 consecutive Crohn's disease (CD) patients was designed to investigate the way in which healthcare utilization is influenced by psychotherapy and relaxation in addition to standardized glucocorticoid therapy. Before and after a I-year period of standardized somatic treatment the psychotherapy and control groups were compared with regard to hospital and sick-leave days. Predictors of healthcare utilization were analyzed. Results: The comparison between groups before and after psychological treatment showed a significantly higher decrease of mean hospital days (P < 0.03) and sick-leave days in the treatment group compared with the controls. When a covariate analysis was applied to compare the data at randomization, the difference in hospital days remained statistically a trend (P < 0.1). Multivariate regression analysis detected a significant gender and depression effect for hospital days (cor r(2) = 0.114) and a significant gender and age effect for sick-leave days (cor r(2) = 0.112). Conclusion: A significant drop in healthcare utilization after psychological treatment demonstrates a clear benefit of this additional therapy. This is important, since the study failed to demonstrate significant changes in the psychosocial status or somatic course of study patients. Clinical and psychological factors influencing these outcomes are discussed.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
  • [1] Psychological treatment in Crohn's disease
    不详
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2004, 56 (06) : 697 - 697
  • [2] Ultrasound scanning may reduce the need for barium radiology in the assessment of small-bowel Crohn's disease
    Bremner, AR
    Pridgeon, J
    Fairhurst, J
    Beattie, RM
    ACTA PAEDIATRICA, 2004, 93 (04) : 479 - 481
  • [3] Does ciprofloxacin reduce the need for surgery in perianal Crohn's disease
    Pakneshan, Sahar
    Hong, Zhen
    Matarise, Batsirai
    Norrie, Mark
    Ostrowski, Szymon
    Shahzad, Muhammad Asif
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 162 - 163
  • [4] Factors that may predict the need for infliximab optimization in Crohn's disease
    Flores, C.
    Petry, R.
    Bortolin Fonseca, C.
    Dos Santos Harlacher, L.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S292 - S292
  • [5] Psychological impact of a stoma in patients with Crohn's disease
    Wilson, J. L.
    Lidgerwood, A.
    Knowles, S.
    Whitworth, F.
    Salzberg, M.
    Castle, D.
    Connell, W. R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A192 - A192
  • [6] Steroids may reduce the benefit of exclusive enteral diet in Crohn's disease
    Amil Dias, J.
    Trindade, E.
    Tavares, M.
    Goncalves, J. P.
    Quaresma, L.
    Ratola, A.
    Rego, H.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S431 - S432
  • [7] HIGHER LEVELS OF INFLIXIMAB MAY ALLEVIATE THE NEED OF AZATHIOPRINE COMEDICATION IN THE TREATMENT OF PATIENTS WITH CROHN'S DISEASE: A SONIC POST HOC ANALYSIS
    Colombel, Jean Frederic
    Adedokun, Omoniyi J.
    Gasink, Christopher
    Tang, Kezhen L.
    Cornillie, Freddy
    D'Haens, Geert R.
    Rutgeerts, Paul
    Reinisch, Walter
    Sandborn, William J.
    Hanauer, Stephen B.
    GASTROENTEROLOGY, 2017, 152 (05) : S37 - S38
  • [8] Higher levels of infliximab may alleviate the need of azathioprine comedication in the treatment of patients with Crohn's disease: a SONIC post hoc analysis
    Colombel, J. -F.
    Adedokun, O. J.
    Gasink, C.
    Tang, K.
    Cornillie, F.
    D'Haens, G.
    Rutgeerts, P.
    Reinisch, W.
    Sandborn, W.
    Hanauer, S.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S135 - S136
  • [9] On Demand Treatment of Crohn's Disease Patients With Infliximab is Associated With Increased Need for Later Treatment With Adalimumab
    Levi, Zohar
    Krongrad, Rivka
    Niv, Yaron
    Fraser, Gerald
    GASTROENTEROLOGY, 2010, 138 (05) : S675 - S675
  • [10] Natalizumab in the treatment of Crohn's disease patients
    Pagnini, Cristiano
    Arseneau, Kristen O.
    Cominelli, Fabio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (11) : 1433 - 1438